Markov state models and NMR uncover an overlooked allosteric loop in p53

被引:28
作者
Barros, Emilia P. [1 ]
Demir, Ozlem [1 ]
Soto, Jenaro [2 ]
Cocco, Melanie J. [2 ,3 ]
Amaro, Rommie E. [1 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA
[3] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
关键词
70;
D O I
10.1039/d0sc05053a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The tumor suppressor p53 is the most frequently mutated gene in human cancer, and thus reactivation of mutated p53 is a promising avenue for cancer therapy. Analysis of wildtype p53 and the Y220C cancer mutant long-timescale molecular dynamics simulations with Markov state models and validation by NMR relaxation studies has uncovered the involvement of loop L6 in the slowest motions of the protein. Due to its distant location from the DNA-binding surface, the conformational dynamics of this loop has so far remained largely unexplored. We observe mutation-induced stabilization of alternate L6 conformations, distinct from all experimentally-determined structures, in which the loop is both extended and located further away from the DNA-interacting surface. Additionally, the effect of the L6-adjacent Y220C mutation on the conformational landscape of the functionally-important loop L1 suggests an allosteric role to this dynamic loop and the inactivation mechanism of the mutation. Finally, the simulations reveal a novel Y220C cryptic pocket that can be targeted for p53 rescue efforts. Our approach exemplifies the power of the MSM methodology for uncovering intrinsic dynamic and kinetic differences among distinct protein ensembles, such as for the investigation of mutation effects on protein function.
引用
收藏
页码:1891 / 1900
页数:10
相关论文
共 70 条
[1]   Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant [J].
Basse, Nicolas ;
Kaar, Joel L. ;
Settanni, Giovanni ;
Joerger, Andreas C. ;
Rutherford, Trevor J. ;
Fersht, Alan R. .
CHEMISTRY & BIOLOGY, 2010, 17 (01) :46-56
[2]   A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C [J].
Bauer, Matthias R. ;
Jones, Rhiannon N. ;
Tareque, Raysa K. ;
Springett, Bradley ;
Dingler, Felix A. ;
Verduci, Lorena ;
Patel, Ketan J. ;
Fersht, Alan R. ;
Joerger, Andreas C. ;
Spencer, John .
FUTURE MEDICINAL CHEMISTRY, 2019, 11 (19) :2491-2504
[3]   Deconstructing p53 transcriptional networks in tumor suppression [J].
Bieging, Kathryn T. ;
Attardi, Laura D. .
TRENDS IN CELL BIOLOGY, 2012, 22 (02) :97-106
[4]   Targeted rescue of a destabilized mutant of p53 by an in silico screened drug [J].
Boeckler, Frank M. ;
Joerger, Andreas C. ;
Jaggi, Gaurav ;
Rutherford, Trevor J. ;
Veprintsev, Dmitry B. ;
Fersht, Alan R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (30) :10360-10365
[5]  
Bowman GR, 2014, ADV EXP MED BIOL, V797, P1, DOI 10.1007/978-94-007-7606-7
[6]   Accurately Modeling Nanosecond Protein Dynamics Requires at least Microseconds of Simulation [J].
Bowman, Gregory R. .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2016, 37 (06) :558-566
[7]   Discovery of multiple hidden allosteric sites by combining Markov state models and experiments [J].
Bowman, Gregory R. ;
Bolin, Eric R. ;
Hart, Kathryn M. ;
Maguire, Brendan C. ;
Marqusee, Susan .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (09) :2734-2739
[8]   Awakening guardian angels: drugging the p53 pathway [J].
Brown, Christopher J. ;
Lain, Sonia ;
Verma, Chandra S. ;
Fersht, Alan R. ;
Lane, David P. .
NATURE REVIEWS CANCER, 2009, 9 (12) :862-873
[9]   Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy [J].
Bullock, AN ;
Henckel, J ;
Fersht, AR .
ONCOGENE, 2000, 19 (10) :1245-1256
[10]   Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs [J].
Bykov, VJN ;
Issaeva, N ;
Zache, N ;
Shilov, A ;
Hultcrantz, M ;
Bergman, J ;
Selivanova, G ;
Wiman, KG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (34) :30384-30391